Disgorgement part of calculus for filing Opana, Lidoderm case in federal court, McSweeny says
The US Federal Trade Commission chose to bring a case challenging alleged reverse-payments on the drugs Opana ER and Lidoderm in federal court rather than through its administrative process, in part,...To view the full article, register now.
Already a subscriber? Click here to view full article